Perbedaan Diagnos Laboratorium Utama Tbk. dan Summarecon Agung Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Summarecon Agung Tbk. diperdagangkan di Rp290 (kapitalisasi pasar 4,79 T, volume 24 jam 8,87 jt). Perbedaan utamanya: Summarecon Agung Tbk. jauh lebih besar — sekitar 15,4× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Summarecon Agung Tbk. lebih aktif diperdagangkan (8,87 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | SMRA | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 4,79 T |
Volume | 963,6 rb | 8,87 jt |
Lot | 9,64 rb | 88,74 rb |
Perputaran | 217,67 jt | 2,58 M |
Harga Rata-rata | 225,89 | 291,2 |
Nilai Transaksi | 217,67 jt | 2,58 M |
Harga Ekuilibrium Indikatif | 226 | 290 |
Volume Ekuilibrium Indikatif | 1 rb | 866 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Selengkapnya di halaman SMRA →